title: European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries.
abstract: BACKGROUND
  The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR.
  
  
  METHODS
  Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled.
  
  
  RESULTS
  The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year).
  
  
  CONCLUSIONS
  The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM.
authors: Department of Cardiology, Robert Bosch Medical Center, Auerbachstrasse 110, 70376 Stuttgart, Germany.
authors: Oliver
authors: O
authors: Bruder
authors: Anja
authors: A
authors: Wagner
authors: Massimo
authors: M
authors: Lombardi
authors: Jürg
authors: J
authors: Schwitter
authors: Albert
authors: A
authors: van Rossum
authors: Günter
authors: G
authors: Pilz
authors: Detlev
authors: D
authors: Nothnagel
authors: Henning
authors: H
authors: Steen
authors: Steffen
authors: S
authors: Petersen
authors: Eike
authors: E
authors: Nagel
authors: Sanjay
authors: S
authors: Prasad
authors: Julia
authors: J
authors: Schumm
authors: Simon
authors: S
authors: Greulich
authors: Alessandro
authors: A
authors: Cagnolo
authors: Pierre
authors: P
authors: Monney
authors: Christina C
authors: CC
authors: Deluigi
authors: Thorsten
authors: T
authors: Dill
authors: Herbert
authors: H
authors: Frank
authors: Georg
authors: G
authors: Sabin
authors: Steffen
authors: S
authors: Schneider
authors: Heiko
authors: H
authors: Mahrholdt
mesh_terms: D000368:Aged; D016009:Chi-Square Distribution; D005060:Europe; D005260:Female; D006331:Heart Diseases / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D053208:Kaplan-Meier Estimate; D008279:Magnetic Resonance Imaging / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D011237:Predictive Value of Tests; D011379:Prognosis; D012042:Registries; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D014022:Tissue Survival